Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Kinaxis Inc. Reports Fourth Quarter 2023 Results

T.KXS

  • FY 2023 delivers 24% SaaS revenue growth and 18% adjusted EBITDA1 margin
  • Q4 SaaS revenue grows 19%, adjusted EBITDA1 margin of 18%, annual recurring revenue2 grows 18%
  • Record RPO and free cash flow reflects strength of business and focus on profitability
  • Repurchased approximately 329,000 common shares for $36.6 million

Kinaxis® (TSX:KXS), the leading provider of supply chain management solutions, reported results for its fourth quarter and year ended December 31, 2023. All amounts are in U.S. dollars. All figures are prepared in accordance with International Financial Reporting Standards (IFRS) unless otherwise indicated.

“We finished the year with a record number of customer wins, a record backlog that provides strong visibility into 2024 and beyond, and record free cash flow. These achievements were won through a persistently high win rate against key competitors, ongoing progress penetrating all tiers of our markets, strong renewals and expansions, ongoing enhancement of the value we offer, and a focus on balancing rapid growth with profitability,” said John Sicard, president and chief executive officer at Kinaxis. “More and more, we are seeing siloed, legacy methods giving way to end-to-end supply chain orchestration, where Kinaxis is the acknowledged leader. We have made strong investments over the past few years that have put us in excellent position to capture even more share in our markets while we make steady progress towards our mid-term profitability goals.”

Q4 2023 Highlights

$ USD thousands, except as otherwise indicated

Q4 2023

Q4 2022

Change

Total Revenue

111,990

98,483

14%

SaaS

69,891

58,839

19%

Subscription term licenses

2,899

9,131

(68)%

Professional services

34,318

26,156

31%

Maintenance and support

4,882

4,357

12%

Gross profit

68,890

61,266

12%

Margin

62%

62%

Profit

4,021

8,562

(53)%

Per diluted share

$0.14

$0.30

Adjusted EBITDA1

19,727

21,116

(7)%

Margin

18%

21%

Cash from (used in) operating activities

27,969

(2,327)

1,302%

(1) “Adjusted EBITDA” is a non-IFRS measures that is not a recognized, defined or standardized measure under IFRS. This measure as well as any other non-IFRS financial measures reported by Kinaxis are defined in the “Non-IFRS Measures” section of this news release.

FY 2023 Highlights

$ USD thousands, except as otherwise indicated

FY 2023

FY 2022

Change

Total Revenue

426,971

366,889

16%

SaaS Revenue

265,080

213,306

24%

Adjusted EBITDA1

74,872

79,446

(6)%

Margin

18%

22%

Key Performance Indicators

The company’s Annual Recurring Revenue2 (ARR), which includes subscription amounts related to both SaaS and on-premise contracts, rose 18% to $322 million at the end of the quarter.

$USD millions

Q4 2023

Q4 2022

Change

Annual recurring revenue2

$

322

$

274

18

%

(2) Annual Recurring Revenue (ARR) is the total annualized value of recurring subscription amounts (ultimately recognized as SaaS, Subscription term licenses and Maintenance and support revenue) of all subscription contracts at a point in time. Annualized subscription amounts are determined solely by reference to the underlying contracts, normalizing for the varying revenue recognition treatments under IFRS 15 for cloud-based versus on-premise subscription amounts. It excludes one-time fees, such as for non-recurring professional services, and assumes that customers will renew the contractual commitments on a periodic basis as those commitments come up for renewal, unless such renewal is known to be unlikely. We believe that this measure provides a more current indication of our performance in the growth of our subscription business than other metrics.

The nature of the company’s long-term contracts provides visibility into future, contracted revenue. The following table presents revenue expected to be recognized in the future related to performance obligations that are unsatisfied (or partially unsatisfied) at December 31, 2023.

$USD millions

2024

2025

2026 and later

Total

SaaS

274.0

197.7

228.9

700.6

Maintenance and support

17.5

12.4

8.3

38.2

Subscription term licenses

2.2

0.1

2.3

Total

293.7

210.2

237.2

741.1

Financial Guidance

Kinaxis is introducing its fiscal 2024 financial guidance, as follows.

FY 2024 Guidance

Total revenue

$483-495 million

SaaS

17-19% growth

Subscription term license

$9-11 million

Adjusted EBITDA1 margin

16-18%

"We are steadily marching towards our baseline mid-term Adjusted EBITDA margin target of 25%. Our 2024 guidance reflects the current ARR growth level, ongoing operating leverage, but also the impacts of being at the low point in our normal cycle for our high-margin subscription term license revenue and our current transition to public cloud, which involves some duplicative costs. Normalizing for these two items better demonstrates our steady progress,” said Blaine Fitzgerald, chief financial officer at Kinaxis. "I am particularly pleased to have generated a record $77.1 million in free cash flow in 2023, which is over 70% higher than in any other year. It's another data point that demonstrates our focus on balancing strong growth and profitability."

Guidance in this press release is provided to enhance visibility into Kinaxis’ expectations for financial targets for the periods indicated. Please refer to the section regarding forward-looking statements that forms an integral part of this release. This press release along with the financial statements and MD&A for the quarter ended December 31, 2023 are available on Kinaxis’ website and on SEDAR at www.sedar.com.

Conference Call

Kinaxis will host a conference call tomorrow, February 29, 2024, to discuss these results. John Sicard, chief executive officer, and Blaine Fitzgerald, chief financial officer, will host the call starting at 8:30 a.m. Eastern Time. A question and answer session will follow management's presentation. Investors and participants must register for the call in advance. See registration link below. Please call the conference telephone number fifteen minutes prior to the start time.

DATE:

Thursday, February 29, 2024

TIME:

8:30 a.m. Eastern Time

CALL REGISTRATION:

https://registrations.events/direct/Q4I914168

WEBCAST

https://events.q4inc.com/attendee/409673001 (available for three months)

REPLAY:

(800)-770-2030 or (609) 800-9909

Available through March 14, 2024

Reference number: 91416

About Kinaxis Inc.

Kinaxis is a global leader in modern supply chain management. We serve supply chains and the people who manage them in service of humanity. Our software is trusted by renowned global brands to provide the agility and predictability needed to navigate today’s volatility and disruption. We combine our patented concurrency technique with a human-centered approach to AI to empower businesses of all sizes to orchestrate their end-to-end supply chain network, from multi-year strategic planning through down-to-the-second execution and last-mile delivery. For more news and information, please visit kinaxis.com or follow us on LinkedIn.

Non-IFRS Measures

Adjusted EBITDA and Adjusted EBITDA Margin

This press release contains non-IFRS measures, specifically Adjusted EBITDA and Adjusted EBITDA margin. We use Adjusted EBITDA to provide investors with a supplemental measure of our operating performance and thus highlight trends in our core business that may not otherwise be apparent when relying solely on IFRS financial measures. We believe that securities analysts, investors and other interested parties frequently use non-IFRS measures in the evaluation of issuers. Management also uses non-IFRS measures in order to facilitate operating performance comparisons from period to period, prepare annual operating budgets and assess our ability to meet our capital expenditure and working capital requirements. Adjusted EBITDA and Adjusted EBITDA margins are not recognized, defined or standardized measures under IFRS. Our definition of Adjusted EBITDA and Adjusted EBITDA margin will likely differ from that used by other companies (including our peers) and therefore comparability may be limited. Non-IFRS measures should not be considered a substitute for or in isolation from measures prepared in accordance with IFRS. Investors are encouraged to review our financial statements and disclosures in their entirety and are cautioned not to put undue reliance on non-IFRS measures and view them in conjunction with the most comparable IFRS financial measures. Kinaxis has reconciled Adjusted EBITDA to the most comparable IFRS financial measure as follows:

Three months ended December 31,

Year ended December 31,

2023

2022

2023

2022

(In thousands of USD)

(In thousands of USD)

Profit

4,021

8,562

10,060

20,080

Change in fair value of contingent consideration

1,367

1,951

(826

)

Share-based compensation

8,388

7,558

34,507

26,238

Adjusted profit

12,409

17,487

46,518

45,492

Income tax expense (recovery)

4,791

(635

)

9,676

11,406

Depreciation and amortization

6,424

6,761

26,284

25,060

Foreign exchange loss (gain)

(797

)

(1,648

)

1,236

(1,499

)

Net finance income

(3,100

)

(849

)

(8,842

)

(1,013

)

7,318

3,629

28,354

33,954

Adjusted EBITDA

19,727

21,116

74,872

79,446

Adjusted EBITDA as a percentage of revenue

17.6

%

21.4

%

17.5

%

21.7

%

Forward-Looking Statements

Certain statements in this release constitute forward-looking statements within the meaning of applicable securities laws. Forward-looking statements include statements as to our expectations for:

  • growth of annual total revenue, annual SaaS and Subscription term licenses revenue, and our expectations for Adjusted EBITDA margin achievement, in each case looking forward for our fiscal year ending December 31, 2024;
  • SaaS growth and increased profitability in years beyond 2024; and
  • contracted revenue in future periods, including 2024, 2025 and 2026 and later.

This release also includes forward-looking statements as to Kinaxis’ growth opportunities and the potential benefits of, and markets and demand for, Kinaxis’ products and services. These statements are subject to certain assumptions, risks and uncertainties, including our view of the relative position of Kinaxis’ products and services compared to competitive offerings in the industry.

In particular, our guidance for 2024 annual total revenue, annual SaaS and Subscription term license revenue and annual Adjusted EBITDA margin, as well as our comments on our expectations for SaaS growth and increased profitability in years beyond 2024, are subject to certain assumptions and associated risks including:

  • our ability to win business from new customers and expand business from existing customers;
  • the timing of new customer wins and expansion decisions by our existing customers;
  • maintaining our customer retention levels, and specifically, that customers will renew contractual commitments on a periodic basis as those commitments come up for renewal, at rates consistent with our historic experience;
  • fluctuations in the value of foreign currencies relative to the U.S. Dollar; and
  • with respect to Adjusted EBITDA and profitability, our ability to contain expense levels while expanding our business.

Our guidance and commentary for achievement of contracted revenue in future periods, including in 2024, 2025 and 2026 and later, is based on assumptions and associated risks including:

  • our ability to satisfy material unperformed obligations under our long-term contracts; and
  • the continued financial capacity and creditworthiness of our customers under long-term contracts.

These and other assumptions, risks and uncertainties may cause Kinaxis’ actual results, performance, achievements and developments to differ materially from the results, performance, achievements or developments expressed or implied by forward-looking statements. Material risks and uncertainties relating to our business are described under the headings “Forward-Looking Statements” and “Risks and Uncertainties” in our annual MD&A dated February 28, 2024, under the heading “Risk Factors” in our Annual Information Form dated March 3, 2023 and in our other public documents filed with Canadian securities regulatory authorities, which are available at www.sedar.com. Forward-looking statements are provided to help readers understand management’s expectations as at the date of this release and may not be suitable for other purposes. Readers are cautioned not to place undue reliance on forward-looking statements. Kinaxis assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by law.

SOURCE: Kinaxis Inc.

Kinaxis Inc.

Consolidated Statements of Financial Position

(Expressed in thousands of USD)

December 31,

2023

December 31,

2022

Assets

Current assets:

Cash and cash equivalents

174,844

175,347

Short-term investments

118,118

50,476

Trade and other receivables

156,609

157,657

Prepaid expenses

14,810

13,660

464,381

397,140

Non-current assets:

Unbilled receivables

3,155

7,245

Other receivables

972

971

Prepaid expenses

1,130

2,395

Investment tax credits recoverable

8,362

7,591

Deferred tax assets

1,184

1,065

Contract acquisition costs

27,438

24,892

Property and equipment

40,300

51,852

Right-of-use assets

47,109

53,537

Intangible assets

23,394

28,271

Goodwill

74,556

73,314

227,600

251,133

691,981

648,273

Liabilities and Shareholders’ Equity

Current liabilities:

Trade payables and accrued liabilities

39,700

40,107

Deferred revenue

137,598

133,467

Provisions

296

Contingent consideration

9,146

Lease obligations

5,805

6,991

183,103

190,007

Non-current liabilities:

Lease obligations

45,985

49,977

Deferred tax liabilities

8,065

6,861

54,050

56,838

Shareholders’ equity:

Share capital

307,327

244,713

Contributed surplus

44,339

65,129

Accumulated other comprehensive gain (loss)

1,360

(156

)

Retained earnings

101,802

91,742

454,828

401,428

691,981

648,273

Kinaxis Inc.

Consolidated Statements of Comprehensive Income

(Expressed in thousands of USD, except share and per share data)

Three months ended December 31,

Year ended December 31,

2023

2022

2023

2022

Revenue

$

111,990

$

98,483

$

426,971

$

366,889

Cost of revenue

43,100

37,217

168,074

131,102

Gross profit

68,890

61,266

258,897

235,787

Operating expenses:

Selling and marketing

26,606

21,213

102,719

79,446

Research and development

20,665

19,494

81,707

74,147

General and administrative

16,703

13,804

60,369

54,273

63,974

54,511

244,795

207,866

4,916

6,755

14,102

27,921

Other income:

Foreign exchange gain (loss)

797

1,648

(1,236

)

1,499

Net finance and other income

3,099

891

8,821

1,240

Change in fair value of contingent consideration

(1,367

)

(1,951

)

826

3,896

1,172

5,634

3,565

Profit before income taxes

8,812

7,927

19,736

31,486

Income tax expense (recovery):

4,791

(635

)

9,676

11,406

Profit

4,021

8,562

10,060

20,080

Other comprehensive income:

Items that are or may be reclassified subsequently to profit:

Foreign currency translation differences - foreign operations

2,543

4,539

1,075

441

Change in net unrealized gain on cash flow hedges

804

441

3,347

4,539

1,516

441

Total comprehensive income

$

7,368

$

13,101

$

11,576

$

20,521

Basic earnings per share

$

0.14

$

0.31

$

0.36

$

0.73

Weighted average number of basic Common Shares

28,114,987

27,903,102

28,321,874

27,667,100

Diluted earnings per share

$

0.14

$

0.30

$

0.35

$

0.70

Weighted average number of diluted Common Shares

28,863,575

28,790,951

29,149,535

28,609,603

Kinaxis Inc.

Consolidated Statements of Changes in Shareholders’ Equity

(Expressed in thousands of USD)

Accumulated other comprehensive income (loss)

Share

capital

Contributed

surplus

Cash flow

hedges

Currency

translation

adjustments

Total

Retained

earnings

Total equity

Balance, December 31, 2021

$

195,414

$

54,739

$

$

(597

)

$

(597

)

$

71,662

$

321,218

Profit

20,080

20,080

Other comprehensive income

441

441

441

Total comprehensive income

441

441

20,080

20,521

Share options exercised

38,791

(9,076

)

29,715

Restricted share units vested

10,091

(10,091

)

Performance share units vested

417

(417

)

Share based payments

29,974

29,974

Total shareholder transactions

49,299

10,390

59,689

Balance, December 31, 2022

244,713

65,129

(156

)

(156

)

91,742

401,428

Profit

10,060

10,060

Other comprehensive income

441

1,075

1,516

1,516

Total comprehensive income

441

1,075

1,516

10,060

11,576

Share options exercised

41,545

(9,991

)

31,554

Restricted share units vested

10,676

(10,676

)

Performance share units vested

2,628

(2,628

)

Share based payments

35,788

35,788

Shares issued for contingent consideration

11,097

11,097

Shares re-purchased

(3,332

)

(33,283

)

(36,615

)

Total shareholder transactions

62,614

(20,790

)

41,824

Balance, December 31, 2023

307,327

44,339

441

919

1,360

101,802

454,828

Kinaxis Inc.

Consolidated Statements of Cash Flows

(Expressed in thousands of USD)

Three months ended December 31,

Year ended December 31,

2023

2022

2023

2022

Cash flows from (used in) operating activities:

Profit

$

4,021

$

8,562

$

10,060

$

20,080

Items not affecting cash:

Depreciation of property and equipment and right-of-use assets

5,093

5,363

20,880

21,496

Amortization of intangible assets

1,331

1,398

5,404

3,564

Share-based payments

8,388

7,558

34,507

26,238

Net finance income

(3,100

)

(849

)

(8,842

)

(1,013

)

Change in fair value of contingent consideration

1,367

1,951

(826

)

Income tax expense (recovery)

4,791

(635

)

9,676

11,406

Investment tax credits recoverable

1,463

(601

)

(771

)

(3,975

)

Change in operating assets and liabilities

4,633

(24,064

)

5,369

(49,123

)

Interest received

2,508

1,087

7,853

2,546

Interest paid

(393

)

(444

)

(1,640

)

(1,841

)

Income taxes paid

(766

)

(1,069

)

(5,090

)

(4,034

)

27,969

(2,327

)

79,357

24,518

Cash flows from (used in) investing activities:

Acquisition of business, net of cash acquired

(76

)

(36,738

)

Purchase of property and equipment and intangible assets

(289

)

(8,169

)

(2,299

)

(18,249

)

Purchase of short-term investments

(32,955

)

(35,149

)

(205,679

)

(80,314

)

Redemption of short-term investments

45,501

15,149

140,666

60,314

12,257

(28,245

)

(67,312

)

(74,987

)

Cash flows from (used in) financing activities:

Payment of lease obligations

(1,729

)

(1,770

)

(6,974

)

(6,733

)

Lease incentives received

3,858

Repurchase of shares

(36,615

)

(36,615

)

Proceeds from exercise of stock options

10,839

6,345

31,554

29,715

(27,505

)

4,575

(12,035

)

26,840

Increase (decrease) in cash and cash equivalents

12,721

(25,997

)

10

(23,629

)

Cash and cash equivalents, beginning of year

160,303

202,764

175,347

203,220

Effects of exchange rates on cash and cash equivalents

$

1,820

$

(1,420

)

$

(513

)

$

(4,244

)

Cash and cash equivalents, end of year

174,844

175,347

174,844

175,347